---
figid: PMC6468754__cancers-11-00316-g002
figtitle: Vascular endothelial growth factor (VEGF) binds to the VEGF receptor, a
  receptor tyrosine kinase, leading to receptor dimerization and subsequent auto phosphorylation
  of the receptor complex
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6468754
filename: cancers-11-00316-g002.jpg
figlink: /pmc/articles/PMC6468754/figure/cancers-11-00316-f002/
number: F2
caption: Vascular endothelial growth factor (VEGF) binds to the VEGF receptor, a receptor
  tyrosine kinase, leading to receptor dimerization and subsequent auto phosphorylation
  of the receptor complex. The phosphorylated receptor then interacts with a variety
  of cytoplasmic signaling molecules, leading to signal transduction and eventually
  angiogenesis. Examples of clinical drugs () that inhibit the pathway are shown.
  PI3K, phosphoinositide-3-kinase; AKT, protein kinase B; mTOR, mechanistic target
  of rapamycin; MEK, MAPK/ERK kinase; ERK, extracellular signal-regulated kinase.
papertitle: Tumor Neovascularization and Developments in Therapeutics.
reftext: Yuki Katayama, et al. Cancers (Basel). 2019 Mar;11(3):316.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9526137
figid_alias: PMC6468754__F2
figtype: Figure
redirect_from: /figures/PMC6468754__F2
ndex: 1429d542-dea4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6468754__cancers-11-00316-g002.html
  '@type': Dataset
  description: Vascular endothelial growth factor (VEGF) binds to the VEGF receptor,
    a receptor tyrosine kinase, leading to receptor dimerization and subsequent auto
    phosphorylation of the receptor complex. The phosphorylated receptor then interacts
    with a variety of cytoplasmic signaling molecules, leading to signal transduction
    and eventually angiogenesis. Examples of clinical drugs () that inhibit the pathway
    are shown. PI3K, phosphoinositide-3-kinase; AKT, protein kinase B; mTOR, mechanistic
    target of rapamycin; MEK, MAPK/ERK kinase; ERK, extracellular signal-regulated
    kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - ras
  - Ras64B
  - Ras85D
  - Akt
  - Raf
  - Mtor
  - Tor
  - Erk7
  - rl
  - CycE
  - cyc
  - Dsor1
  - Mtk
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - KDR
  - FLT1
  - FLT4
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - Sunitinib
  - Sorafenib
  - Axitinib
  - Pazopanib
  - Vandetanib
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
